This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brugge, W. R. Search for Related Content PubMed PubMed Citation Articles by Brugge, W. R. Social Bookmarking                            What's this?

Endoscopic Techniques to Diagnose and Manage Biliary Tumors

William R. Brugge

From the Gastrointestinal Endoscopy Unit, Massachusetts General Hospital, Boston, MA

Address reprint requests to William Brugge, MD, Massachusetts General Hospital, Blake 452c, Boston, MA 02114; e-mail: WBrugge{at}partners.org.

Malignancies of the bile duct are often suspected in patients with abnormal serum hepatic enzyme levels and obstruction of the biliary system. Although cross-sectional imaging can provide evidence for biliary obstruction and a malignancy arising from the bile duct, a definitive diagnosis is often obtained through the use of endoscopic procedures. Endoscopic retrograde cholangiopancreatography (ERCP), the most commonly performed procedure for cholangiocarcinoma, can provide a tissue diagnosis through brush cytology of the bile duct. Relief from biliary obstruction can be provided with temporary plastic stenting or permanent metal stenting. Photodynamic therapy guided by ERCP may provide improved palliation from biliary obstruction in the future. Endoscopic ultrasonography complements the role of ERCP and may provide a tissue diagnosis through fine-needle aspiration and staging through ultrasound imaging. High-resolution ultrasound images can provide detailed information regarding the relationship between a mass and the bile duct wall. Despite these advances in endoscopic techniques and imaging of the bile duct, a tissue diagnosis often remains elusive in many patients. In the future, molecular markers will be employed to improve the sensitivity for the detection of malignancy in bile duct samples obtained through brushing, aspiration, and biopsy.

Author's disclosure of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				N. I. Sainani, O. A. Catalano, N.-S. Holalkere, A. X. Zhu, P. F. Hahn, and D. V. Sahani Cholangiocarcinoma: Current and Novel Imaging Techniques1 RadioGraphics, September 1, 2008; 28(5): 1263 - 1287. [Abstract] [Full Text] [PDF]

				T Kitiyakara and R W Chapman Chemoprevention and screening in primary sclerosing cholangitis Postgrad. Med. J., May 1, 2008; 84(991): 228 - 237. [Abstract] [Full Text] [PDF]